Neuroligin-Neurexin Interaction
From Proteopedia
(Difference between revisions)
Line 3: | Line 3: | ||
Experimental results from the past 10 years have revealed that loss of Neuroligin function has a selective reductive effect on inhibitory synapse function indicating that functional inhibitory synapses rely more heavily on neuroligins than do excitatory synapses.<ref name="Chih"/> This was an astonishing discovery as [[Autism Spectrum Disorders]] (ASDs) have long been attributed to perturbations in the Excitatory/Inhibitory (E/I) synaptic signal ratios within the brain. Knockdown studies have validated that the selective knockdown of NLGNs resulted in a significant imbalance of E/I transmission possibly altering oscillatory rhythms in the brain.<ref name="Kat"/><ref name="Chih"/> As Sudhof et al. point out, a major reason for the difficitulties in understanding cognitive diseases is that they arise from subtle changes in a subset of synapses as opposed to obvious impairment of all synapses in all circuits.<ref name="Sudhof"/> The altered E/I ratios associated with NLGN dysfunction may be an example of such a “subtle change”. Indeed, mice with loss-of function mutations in NLGN4 exhibit deficits in social interactions and communication that are reminiscent of ASDs.<ref>PMID:18227507</ref> Of particular interest are those NLGN3 mutations like R451C in which mice have the impaired social ability but elevated learning capacity manifestations reminiscent of “savant” syndrome.<ref name="Kat"/> In all, seven point mutations, two translocations and four large-scale deletions in the NRXN1 gene were detected in patients with autism.<ref name="Sudhof"/> These mutations however were only found in a small percentage of Autism patients and are occasionally present in non-symptomatic siblings. Thus, these mutations may only increase the chance of autism rather than actually causing it.<ref name="Fabrichny">PMID:18093521</ref> | Experimental results from the past 10 years have revealed that loss of Neuroligin function has a selective reductive effect on inhibitory synapse function indicating that functional inhibitory synapses rely more heavily on neuroligins than do excitatory synapses.<ref name="Chih"/> This was an astonishing discovery as [[Autism Spectrum Disorders]] (ASDs) have long been attributed to perturbations in the Excitatory/Inhibitory (E/I) synaptic signal ratios within the brain. Knockdown studies have validated that the selective knockdown of NLGNs resulted in a significant imbalance of E/I transmission possibly altering oscillatory rhythms in the brain.<ref name="Kat"/><ref name="Chih"/> As Sudhof et al. point out, a major reason for the difficitulties in understanding cognitive diseases is that they arise from subtle changes in a subset of synapses as opposed to obvious impairment of all synapses in all circuits.<ref name="Sudhof"/> The altered E/I ratios associated with NLGN dysfunction may be an example of such a “subtle change”. Indeed, mice with loss-of function mutations in NLGN4 exhibit deficits in social interactions and communication that are reminiscent of ASDs.<ref>PMID:18227507</ref> Of particular interest are those NLGN3 mutations like R451C in which mice have the impaired social ability but elevated learning capacity manifestations reminiscent of “savant” syndrome.<ref name="Kat"/> In all, seven point mutations, two translocations and four large-scale deletions in the NRXN1 gene were detected in patients with autism.<ref name="Sudhof"/> These mutations however were only found in a small percentage of Autism patients and are occasionally present in non-symptomatic siblings. Thus, these mutations may only increase the chance of autism rather than actually causing it.<ref name="Fabrichny">PMID:18093521</ref> | ||
- | There are two <scene name='Neuroligin-Neurexin_Interaction/Neurexin_opening/1'>types of Neurexins</scene>, α and β. While α-NRXNs are much larger than β-NRXNs, both contain a single LNS (Laminin, NRXN, sex-hormone-binding globulin domains) domain. Extensive alternative splicing at five unique positions generates thousands of NRXN isoforms which likely specify a “code” of interactions at synapses that varies by location and activity of the neuron.<ref name="Sudhof"/> All NRXN isoforms are found on the presynaptic neuron and have the same <scene name='Neuroligin-Neurexin_Interaction/Jelly_roll/1'>“jelly roll fold”</scene> comprised of 14 beta sheets. The alternative splicing only <scene name='Neuroligin-Neurexin_Interaction/Spliced/1'>impacts one end of the jelly roll</scene>, including sheets 1, 2, 13 & 14 and the lone alpha helix in the LNS domain.<ref>PMID:10520997</ref> | + | There are two <scene name='Neuroligin-Neurexin_Interaction/Neurexin_opening/1'>types of Neurexins</scene>, α and β. While α-NRXNs are much larger than β-NRXNs, both contain a single LNS (Laminin, NRXN, sex-hormone-binding globulin domains) domain. Extensive alternative splicing at five unique positions generates thousands of NRXN isoforms which likely specify a “code” of interactions at synapses that varies by location and activity of the neuron.<ref name="Sudhof"/> All NRXN isoforms are found on the presynaptic neuron surface and have the same <scene name='Neuroligin-Neurexin_Interaction/Jelly_roll/1'>“jelly roll fold”</scene> comprised of 14 beta sheets. The alternative splicing only <scene name='Neuroligin-Neurexin_Interaction/Spliced/1'>impacts one end of the jelly roll</scene>, including sheets 1, 2, 13 & 14 and the lone alpha helix in the LNS domain.<ref>PMID:10520997</ref> |
The <scene name='Neuroligin-Neurexin_Interaction/Neuroligin_dimer_opening/1'>extracellular residues of NLGNs</scene>, which bind to the LNS domains of both alpha and beta NRXNs with nanomolar affinity, are <scene name='Neuroligin-Neurexin_Interaction/Neuroligin_opening/1'>composed of a single domain</scene> that is homologous with [[acetylcholinesterase]] (AChE).<ref name="Sudhof"/> Neuroligin-4, which is expressed on the surface of postsynaptic neurons, consists of a twisted <scene name='Neuroligin-Neurexin_Interaction/Neuroligin_helices_and_sheets/3'>12 stranded beta sheet surrounded by 14 alpha helices</scene>. Three intramolecular <scene name='Neuroligin-Neurexin_Interaction/Neuroligin_disulfide/1'>disulfide bridges</scene> between residues Cys110-Cys146, Cys306-Cys317, and Cys476-Cys510, stabilize the structure. Neuroligins readily <scene name='Neuroligin-Neurexin_Interaction/Dimer/1'>form a dimmer</scene> consisting of two neuroligin subunits. 100% of the dimer <scene name='Neuroligin-Neurexin_Interaction/Hydrophobic_interactions/1'>interactions are hydrophobic</scene> with the most unique feature being a <scene name='Neuroligin-Neurexin_Interaction/4_helix_bundle/2'>prominent four-helix bundle</scene> (<scene name='Neuroligin-Neurexin_Interaction/4_helix_bundle_hydro/1'>Alternate View</scene>).<ref name="Fabrichny"/> The <scene name='Neuroligin-Neurexin_Interaction/Central_pocket/2'>central pocket within Neuroligin</scene>, which in Acetylcholinesterase contains the active center and oxyanion hole, is catalytically inactive due to a substitution of Gly for Ser <scene name='Neuroligin-Neurexin_Interaction/Central_pocket_gly/1'>at position 254</scene>, which is typically part of AChE’s hydrolytic catalytic triad. The <scene name='Neuroligin-Neurexin_Interaction/Cys_loop/3'>so-called Cys-Loop</scene> (Residues Cys110-Cys146) forms one side of the rim of the central pocket and is a homolog of the lid found in [[Lipase|lipases]] of the α/β-hydrolase fold family. This Cys-Loop blocks the entry of substrate to the central pocket and provides stability to the NLGN structure.<ref name="Fabrichny"/> | The <scene name='Neuroligin-Neurexin_Interaction/Neuroligin_dimer_opening/1'>extracellular residues of NLGNs</scene>, which bind to the LNS domains of both alpha and beta NRXNs with nanomolar affinity, are <scene name='Neuroligin-Neurexin_Interaction/Neuroligin_opening/1'>composed of a single domain</scene> that is homologous with [[acetylcholinesterase]] (AChE).<ref name="Sudhof"/> Neuroligin-4, which is expressed on the surface of postsynaptic neurons, consists of a twisted <scene name='Neuroligin-Neurexin_Interaction/Neuroligin_helices_and_sheets/3'>12 stranded beta sheet surrounded by 14 alpha helices</scene>. Three intramolecular <scene name='Neuroligin-Neurexin_Interaction/Neuroligin_disulfide/1'>disulfide bridges</scene> between residues Cys110-Cys146, Cys306-Cys317, and Cys476-Cys510, stabilize the structure. Neuroligins readily <scene name='Neuroligin-Neurexin_Interaction/Dimer/1'>form a dimmer</scene> consisting of two neuroligin subunits. 100% of the dimer <scene name='Neuroligin-Neurexin_Interaction/Hydrophobic_interactions/1'>interactions are hydrophobic</scene> with the most unique feature being a <scene name='Neuroligin-Neurexin_Interaction/4_helix_bundle/2'>prominent four-helix bundle</scene> (<scene name='Neuroligin-Neurexin_Interaction/4_helix_bundle_hydro/1'>Alternate View</scene>).<ref name="Fabrichny"/> The <scene name='Neuroligin-Neurexin_Interaction/Central_pocket/2'>central pocket within Neuroligin</scene>, which in Acetylcholinesterase contains the active center and oxyanion hole, is catalytically inactive due to a substitution of Gly for Ser <scene name='Neuroligin-Neurexin_Interaction/Central_pocket_gly/1'>at position 254</scene>, which is typically part of AChE’s hydrolytic catalytic triad. The <scene name='Neuroligin-Neurexin_Interaction/Cys_loop/3'>so-called Cys-Loop</scene> (Residues Cys110-Cys146) forms one side of the rim of the central pocket and is a homolog of the lid found in [[Lipase|lipases]] of the α/β-hydrolase fold family. This Cys-Loop blocks the entry of substrate to the central pocket and provides stability to the NLGN structure.<ref name="Fabrichny"/> |
Revision as of 04:25, 25 February 2011
|
Additional Structures of Neuroligin and Neurexin
For additional Structures of Neuroligin, See: Neuroligin
For additional Structures of Neurexin, See: Neurexin
References
- ↑ 1.0 1.1 1.2 Chih B, Engelman H, Scheiffele P. Control of excitatory and inhibitory synapse formation by neuroligins. Science. 2005 Feb 25;307(5713):1324-8. Epub 2005 Jan 27. PMID:15681343 doi:10.1126/science.1107470
- ↑ 2.0 2.1 2.2 2.3 2.4 2.5 Sudhof TC. Neuroligins and neurexins link synaptic function to cognitive disease. Nature. 2008 Oct 16;455(7215):903-11. PMID:18923512 doi:10.1038/nature07456
- ↑ 3.0 3.1 3.2 Tabuchi K, Blundell J, Etherton MR, Hammer RE, Liu X, Powell CM, Sudhof TC. A neuroligin-3 mutation implicated in autism increases inhibitory synaptic transmission in mice. Science. 2007 Oct 5;318(5847):71-6. Epub 2007 Sep 6. PMID:17823315 doi:10.1126/science.1146221
- ↑ Jamain S, Radyushkin K, Hammerschmidt K, Granon S, Boretius S, Varoqueaux F, Ramanantsoa N, Gallego J, Ronnenberg A, Winter D, Frahm J, Fischer J, Bourgeron T, Ehrenreich H, Brose N. Reduced social interaction and ultrasonic communication in a mouse model of monogenic heritable autism. Proc Natl Acad Sci U S A. 2008 Feb 5;105(5):1710-5. Epub 2008 Jan 28. PMID:18227507 doi:10.1073/pnas.0711555105
- ↑ 5.0 5.1 5.2 5.3 5.4 Fabrichny IP, Leone P, Sulzenbacher G, Comoletti D, Miller MT, Taylor P, Bourne Y, Marchot P. Structural analysis of the synaptic protein neuroligin and its beta-neurexin complex: determinants for folding and cell adhesion. Neuron. 2007 Dec 20;56(6):979-91. PMID:18093521 doi:10.1016/j.neuron.2007.11.013
- ↑ Rudenko G, Nguyen T, Chelliah Y, Sudhof TC, Deisenhofer J. The structure of the ligand-binding domain of neurexin Ibeta: regulation of LNS domain function by alternative splicing. Cell. 1999 Oct 1;99(1):93-101. PMID:10520997